Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.37/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman starts Talen at buy, sees PJM power tightness boosting earnings
• SpaceX receives Baa1 rating from Moody's with stable outlook